Alonso-GarcÃa, M.; Sánchez-Gastaldo, A.; Muñoz-Fuentes, M.A.; Molina-Pinelo, S.; Boyero, L.; Benedetti, J.C.; Bernabé-Caro, R.
Real-World Analysis of Nivolumab and Atezolizumab Efficacy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer. Pharmaceuticals 2022, 15, 533.
https://doi.org/10.3390/ph15050533
AMA Style
Alonso-GarcÃa M, Sánchez-Gastaldo A, Muñoz-Fuentes MA, Molina-Pinelo S, Boyero L, Benedetti JC, Bernabé-Caro R.
Real-World Analysis of Nivolumab and Atezolizumab Efficacy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer. Pharmaceuticals. 2022; 15(5):533.
https://doi.org/10.3390/ph15050533
Chicago/Turabian Style
Alonso-GarcÃa, Miriam, Amparo Sánchez-Gastaldo, Miguel A. Muñoz-Fuentes, Sonia Molina-Pinelo, Laura Boyero, Johana Cristina Benedetti, and Reyes Bernabé-Caro.
2022. "Real-World Analysis of Nivolumab and Atezolizumab Efficacy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer" Pharmaceuticals 15, no. 5: 533.
https://doi.org/10.3390/ph15050533
APA Style
Alonso-GarcÃa, M., Sánchez-Gastaldo, A., Muñoz-Fuentes, M. A., Molina-Pinelo, S., Boyero, L., Benedetti, J. C., & Bernabé-Caro, R.
(2022). Real-World Analysis of Nivolumab and Atezolizumab Efficacy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer. Pharmaceuticals, 15(5), 533.
https://doi.org/10.3390/ph15050533